Spliceosomal protein e regulates neoplastic cell growth by modulating expression of Cyclin E/CDK2 and G2/M checkpoint proteins

Journal of Cellular and Molecular Medicine

Volumn 12, Issue 6A, 2008, Pages 2427-2438

  Li, Z ^a   Putzer B M ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Cancer; Cell cycle; Growth regulation; Signal transduction; Small nuclear ribonucleoprotein

Indexed keywords

CDC2 PROTEIN, HUMAN; CDC25C PROTEIN, HUMAN; CDK2 PROTEIN, HUMAN; CDKN1B PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN B; CYCLIN DEPENDENT KINASE 2; CYCLIN E; PRIMER DNA; PROTEIN TYROSINE PHOSPHATASE; SIGNAL PEPTIDE; SMALL NUCLEAR RIBONUCLEOPROTEIN; SNRPE PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; BIOLOGICAL MODEL; CELL PROLIFERATION; DRUG ANTAGONISM; GENE; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; NEOPLASM; NUCLEOTIDE SEQUENCE; PATHOLOGY; RNA INTERFERENCE; SPLICEOSOME; TUMOR CELL LINE;

APOPTOSIS; BASE SEQUENCE; CDC25 PHOSPHATASES; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN B; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; DNA PRIMERS; GENE EXPRESSION; GENES, CDC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, BIOLOGICAL; NEOPLASMS; RNA INTERFERENCE; SNRNP CORE PROTEINS; SPLICEOSOMES;

ADENOVIRIDAE;

EID: 47549092583     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00244.x     Document Type: Article

References (44)

1. Dalton S. Cell cycle regulation of the human cdc2 gene. EMBO J. 1992 11 : 1797 804.
2. Ohtani K, DeGregori J, Nevins JR. Regulation of the cyclin E gene by transcription factor E2F1. Proc Natl Acad Sci USA. 1995 92 : 12146 50.
3. Ren B, Cam H, Takahashi Y, Volkert T, Terragni J, Young RA, Dynlacht BD. E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev. 2002 16 : 245 56.
4. Polager S, Ginsberg D. E2F mediates sustained G2 arrest and down-regulation of Stathmin and AIM-1 expression in response to genotoxic stress. J Biol Chem. 2003 278 : 1443 9.
5. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev. 1998 12 : 2245 62.
6. Stevaux O, Dyson NJ. A revised picture of the E2F transcriptional network and RB function. Curr Opin Cell Biol. 2002 14 : 684 91.
7. Dimova DK, Dyson NJ. The E2F transcriptional network: old acquaintances with new faces. Oncogene. 2005 24 : 2810 26.
8. Stanelle J, Pützer BM. E2F1 death pathways as targets for cancer therapy. J Cell Mol Med. 2007 11 : 239 51.
9. Lin WC, Lin FT, Nevins JR. Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phos-phorylation. Genes Dev. 2001 15 : 1833 44.
10. Powers JT, Hong S, Mayhew CN, Rogers PM, Knudsen ES, Johnson DG. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis. Mol Cancer Res. 2004 2 : 203 14.
11. Stevens C, Smith L, La Thangue NB. Chk2 activates E2F-1 in response to DNA damage. Nat Cell Biol. 2003 5 : 401 9.
12. Li Z, Stanelle J, Leurs C, Hanenberg H, Pützer BM. Selection of novel mediators of E2F1-induced apoptosis through retroviral expression of an antisense cDNA library. Nucleic Acids Res. 2005 33 : 2813 21.
13. Mayes AE, Verdone L, Legrain P, Beggs JD. Characterization of Sm-like proteins in yeast and their association with U6 snRNA. EMBO J. 1999 18 : 4321 31.
14. Salgado-Garrido J, Bragado-Nilsson E, Kandels-Lewis S, Seraphin B. Sm and Sm-like proteins assemble in two related complexes of deep evolutionary origin. EMBO J. 1999 18 : 3451 62.
15. Hermann H, Fabrizio P, Raker VA, Foulaki K, Hornig H, Brahms H, Luhrmann R. snRNP Sm proteins share two evolutionarily conserved sequence motifs which are involved in Sm protein-protein interactions. EMBO J. 1995 14 : 2076 88.
16. Seraphin B. Sm and Sm-like proteins belong to a large family: identification of proteins of the U6 as well as the U1, U2, U4 and U5 snRNPs. EMBO J. 1995 14 : 2089 98.
17. Albrecht M, Lengauer T. Novel Sm-like proteins with long C-terminal tails and associated methyltransferases. FEBS Lett. 2004 569 : 18 26.
18. Barbee SA, Evans TC. The Sm proteins regulate germ cell specification during early C. elegans embryogenesis. Dev Biol. 2006 291 : 132 43.
19. Bilinski SM, Jaglarz MK, Szymanska B, Etkin LD, Kloc M. Sm proteins, the constituents of the spliceosome, are components of nuage and mitochondrial cement in Xenopus oocytes. Exp Cell Res. 2004 299 : 171 8.
20. Hajnsdorf E, Regnier P. Host factor Hfq of Escherichia coli stimulates elongation of poly(A) tails by poly(A) polymerase I. Proc Natl Acad Sci USA. 2000 97 : 1501 5.
21. Tan E M. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol. 1989 44 : 93 151.
22. Maddison PJ, Reichlin M. Quantitation of precipitating antibodies to certain soluble nuclear antigens in SLE. Arthritis Rheum. 1977 20 : 819 24.
23. Stanelle J, Stiewe T, Rodicker F, Kohler K, Theseling C, Putzer BM. Mechanism of E2F1-induced apoptosis in primary vascular smooth muscle cells. Cardiovasc Res. 2003 59 : 512 9.
24. Putzer BM, Stiewe T, Crespo F, Esche H. Improved safety through tamoxifen-regulated induction of cytotoxic genes delivered by Ad vectors for cancer gene therapy. Gene Ther. 2000, 7 : 1317 25.
25. Deiss LP, Kimchi A. A genetic tool used to identify thioredoxin as a mediator of a growth inhibitory signal. Science. 1991 252 : 117 20.
26. Urlaub H, Raker VA, Kostka S, Luhrmann R. Sm protein-Sm site RNA interactions within the inner ring of the spliceosomal snRNP core structure. EMBO J. 2001 20 : 187 96.
27. Lacy ER, Wang Y, Post J, Nourse A, Webb W, Mapelli M, Musacchio A, Siuzdak G, Kriwacki RW. Molecular Basis for the Specificity of p27 Toward Cyclin-dependent Kinases that Regulate Cell Division. J Mol Biol. 2005 349 : 764 73.
28. Will CL, Luhrmann R. Protein functions in pre-mRNA splicing. Curr Opin Cell Biol. 1997 9 : 320 8.
29. Putzer BM, Bramson JL, Addison CL, Hitt M, Siegel PM, Muller WJ, Graham FL. Combination therapy with interleukin-2 and wild-type p53 expressed by adenoviral vectors potentiates tumor regression in a murine model of breast cancer. Hum Gene Ther. 1998 9 : 707 18.
30. Sherr CJ. Tumor surveillance via the ARF-p53 pathway. Genes Dev. 1998 12 : 2984 91.
31. Grimes CA, Jope RS. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol. 2001 65 : 391 426.
32. Watcharasit P, Bijur GN, Zmijewski JW, Song L, Zmijewska A, Chen X, Johnson GV, Jope RS. Direct, activating interaction between glycogen synthase kinase-3beta and p53 after DNA damage. Proc Natl Acad Sci. USA. 2002 99 : 7951 5.
33. Loberg RD, Vesely E, Brosius FC, 3rd. Enhanced glycogen synthase kinase-3beta activity mediates hypoxia-induced apopto-sis of vascular smooth muscle cells and is prevented by glucose transport and metabolism. J Biol Chem. 2002 277 : 41667 73.
34. Perez M, Rojo AI, Wandosell F, Diaz-Nido J, Avila J. Prion peptide induces neuronal cell death through a pathway involving glycogen synthase kinase 3. Biochem J. 2003 372 : 129 36.
35. Song L, De Sarno P, Jope RS. Central role of glycogen synthase kinase-3beta in endoplasmic reticulum stress-induced caspase-3 activation. J Biol Chem. 2002 277 : 44701 8.
36. Liu Z, Brattain MG, Appert H. Differential display of reticulocalbin in the highly invasive cell line, MDA-MB-435, versus the poorly invasive cell line, MCF-7. Biochem Biophys Res Commun. 1997 231 : 283 9.
37. Obaya AJ, Sedivy JM. Regulation of cyclin-Cdk activity in mammalian cells. Cell Mol Life Sci. 2002 59 : 126 42.
38. Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM, Pagano M. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol. 1995 15 : 2612 24.
39. Nilsson I, Hoffmann I. Cell cycle regulation by the Cdc25 phosphatase family. Prog Cell Cycle Res. 2000 4 : 107 14.
40. Normand G, Hemmati PG, Verdoodt B, von Haefen C, Wendt J, Guner D, May E, Dorken B, Daniel PT. p14ARF induces G2 cell cycle arrest in p53- and p21-deficient cells by down-regulating p34cdc2 kinase activity. J Biol Chem. 2005 280 : 7118 30.
41. Passalaris TM, Benanti JA, Gewin L, Kiyono T, Galloway DA. The G(2) checkpoint is maintained by redundant pathways. Mol Cell Biol. 1999 19 : 5872 81.
42. Taylor WR, Stark GR. Regulation of the G2/M transition by p53. Oncogene. 2001 20 : 1803 15.
43. Enoch T, Norbury C. Cellular responses to DNA damage: cell-cycle checkpoints, apoptosis and the roles of p53 and ATM. Trends Biochem Sci. 1995 20 : 426 30.
44. Linke SP, Clarkin KC, Wahl GM. p53 mediates permanent arrest over multiple cell cycles in response to gamma-irradiation. Cancer Res. 1997 57 : 1171 9.